Literature DB >> 19377959

T-cell epitope mapping in Mycobacterium tuberculosis using pepmixes created by micro-scale SPOT- synthesis.

Marisa Frieder1, David M Lewinsohn.   

Abstract

Mycobacterium tuberculosis (Mtb) remains a major threat to human health worldwide. Although treatment of infection is an important part of tuberculosis control, an improved vaccine is essential for the elimination of this disease. Control of infection with Mtb is dependent on the cellular immune system, which in turn requires an understanding of those antigens that are capable of stimulating CD4+ and CD8+ T-cell responses. Peptide libraries provide a high-throughput system for identifying novel T-cell epitopes. They can also be used to assess the hierarchy of immunodominance of these novel antigens and epitopes that are associated with infection with Mtb. This T-cell-driven means of antigen discovery is well adapted to vaccine development as well as developing the tools necessary to understand the natural history of this important human pathogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377959     DOI: 10.1007/978-1-59745-450-6_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.

Authors:  Mingjun Wang; Sheila T Tang; Anette Stryhn; Sune Justesen; Mette V Larsen; Morten H Dziegiel; David M Lewinsohn; Søren Buus; Ole Lund; Mogens H Claesson
Journal:  Immunology       Date:  2011-02-07       Impact factor: 7.397

2.  Pepscan Approach for the Identification of Protein-Protein Interfaces: Lessons from Experiment.

Authors:  Angelita Rebollo; Eric Savier; Pierre Tuffery
Journal:  Biomolecules       Date:  2021-05-21

3.  Immune Control of Burkholderia pseudomallei--Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes.

Authors:  Arnone Nithichanon; Darawan Rinchai; Surachat Buddhisa; Pornpun Saenmuang; Chidchamai Kewcharoenwong; Bianca Kessler; Prasong Khaenam; Ploenchan Chetchotisakd; Bernard Maillere; John Robinson; Catherine J Reynolds; Rosemary J Boyton; Daniel M Altmann; Ganjana Lertmemongkolchai
Journal:  Front Immunol       Date:  2018-03-20       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.